DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

• Ana Osorio ,

  * E-mail: aosorio@cnio.es

  Affiliations Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain, Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain

  ⨯
• Roger L. Milne,

  Affiliation Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia

  ⨯
• Karoline Kuchenbaecker,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Tereza Vaclová,

  Affiliation Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain

  ⨯
• Guillermo Pita,

  Affiliation Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain

  ⨯
• Rosario Alonso,

  Affiliation Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain

  ⨯
• Paolo Peterlongo,

  Affiliation IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy

  ⨯
• Ignacio Blanco,

  Affiliation Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain

  ⨯
• Miguel de la Hoya,

  Affiliation Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain

  ⨯
• Mercedes Duran,

  Affiliation Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain

  ⨯
• Orland Díez,

  Affiliation Oncogenetics Laboratory, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Institut de Recerca (VHIR), and Universitat Autonoma de Barcelona, Barcelona, Spain

  ⨯
• Teresa Ramón y Cajal,

  Affiliation Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  ⨯
• Irene Konstantopoulou,

  Affiliation Molecular Diagnostics Laboratory IRRP, National Centre for Scientific Research Demokritos Aghia Paraskevi Attikis, Athens, Greece

  ⨯
• Cristina Martínez-Bouzas,

  Affiliation Molecular Genetics Laboratory (Department of Biochemistry), Cruces Hospital Barakaldo, Bizkaia, Spain

  ⨯
• Raquel Andrés Conejero,

  Affiliation Medical Oncology Service, Hospital Clínico Lozano Blesa, San Juan Bosco, Zaragoza, Spain

  ⨯
• Penny Soucy,

  Affiliation Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada

  ⨯
• Lesley McGuffog,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Daniel Barrowdale,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Andrew Lee,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• SWE-BRCA ,

  ¶Full membership of SWE-BRCA, HEBON and kConFab Investigators is provided in the Acknowledgments.

  Affiliation Department of Oncology, Lund University, Lund, Sweden

  ⨯
• Brita Arver,

  Affiliation Department of Oncology, Karolinska University Hospital, Stockholm, Sweden

  ⨯
• Johanna Rantala,

  Affiliation Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden

  ⨯
• Niklas Loman,

  Affiliation Department of Oncology, Lund University Hospital, Lund, Sweden

  ⨯
• Hans Ehrencrona,

  Affiliation Department of Clinical Genetics, Lund University Hospital, Lund, Sweden

  ⨯
• Olufunmilayo I. Olopade,

  Affiliation Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois, United States of America

  ⨯
• Mary S. Beattie,

  Affiliation Departments of Medicine, Epidemiology, and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Susan M. Domchek,

  Affiliation Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Katherine Nathanson,

  Affiliation Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Timothy R. Rebbeck,

  Affiliation Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Banu K. Arun,

  Affiliation University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Beth Y. Karlan,

  Affiliation Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Christine Walsh,

  Affiliation Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Jenny Lester,

  Affiliation Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Esther M. John,

  Affiliation Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America

  ⨯
• Alice S. Whittemore,

  Affiliation Department of Health Research & Policy, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Mary B. Daly,

  Affiliation Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Melissa Southey,

  Affiliation Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia

  ⨯
• John Hopper,

  Affiliation Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Melbourne, Victoria, Australia

  ⨯
• Mary B. Terry,

  Affiliation Department of Epidemiology, Columbia University, New York, New York, United States of America

  ⨯
• Saundra S. Buys,

  Affiliation Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America

  ⨯
• Ramunas Janavicius,

  Affiliation Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Department of Molecular and Regenerative Medicine, Vilnius, Lithuania

  ⨯
• Cecilia M. Dorfling,

  Affiliation Department of Genetics, University of Pretoria, Pretoria, South Africa

  ⨯
• Elizabeth J. van Rensburg,

  Affiliation Department of Genetics, University of Pretoria, Pretoria, South Africa

  ⨯
• Linda Steele,

  Affiliation Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America

  ⨯
• Susan L. Neuhausen,

  Affiliation Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America

  ⨯
• Yuan Chun Ding,

  Affiliation Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America

  ⨯
• Thomas v. O. Hansen,

  Affiliation Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Lars Jønson,

  Affiliation Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Bent Ejlertsen,

  Affiliation Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Anne-Marie Gerdes,

  Affiliation Department of Clinical Genetics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Mar Infante,

  Affiliation Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain

  ⨯
• Belén Herráez,

  Affiliation Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain

  ⨯
• Leticia Thais Moreno,

  Affiliation Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain

  ⨯
• Jeffrey N. Weitzel,

  Affiliation Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America

  ⨯
• Josef Herzog,

  Affiliation Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America

  ⨯
• Kisa Weeman,

  Affiliation Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America

  ⨯
• Siranoush Manoukian,

  Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy

  ⨯
• Bernard Peissel,

  Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy

  ⨯
• Daniela Zaffaroni,

  Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy

  ⨯
• Giulietta Scuvera,

  Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy

  ⨯
• Bernardo Bonanni,

  Affiliation Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy

  ⨯
• Frederique Mariette,

  Affiliation IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Cogentech Cancer Genetic Test Laboratory, Milan, Italy

  ⨯
• Sara Volorio,

  Affiliation IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Cogentech Cancer Genetic Test Laboratory, Milan, Italy

  ⨯
• Alessandra Viel,

  Affiliation Division of Experimental Oncology 1, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy

  ⨯
• Liliana Varesco,

  Affiliation Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS AOU San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

  ⨯
• Laura Papi,

  Affiliation Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy

  ⨯
• Laura Ottini,

  Affiliation Department of Molecular Medicine, “Sapienza” University, Rome, Italy

  ⨯
• Maria Grazia Tibiletti,

  Affiliation UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy

  ⨯
• Paolo Radice,

  Affiliation Unit of Molecular bases of genetic risk and genetic testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy

  ⨯
• Drakoulis Yannoukakos,

  Affiliation Molecular Diagnostics Laboratory IRRP, National Centre for Scientific Research Demokritos Aghia Paraskevi Attikis, Athens, Greece

  ⨯
• Judy Garber,

  Affiliation Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Steve Ellis,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Debra Frost,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Radka Platte,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Elena Fineberg,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Gareth Evans,

  Affiliation Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom

  ⨯
• Fiona Lalloo,

  Affiliation Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom

  ⨯
• Louise Izatt,

  Affiliation South East Thames Regional Genetics Service, Guy's Hospital London, United Kingdom

  ⨯
• Ros Eeles,

  Affiliation Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom

  ⨯
• Julian Adlard,

  Affiliation Yorkshire Regional Genetics Service, Leeds, United Kingdom

  ⨯
• Rosemarie Davidson,

  Affiliation Ferguson-Smith Centre for Clinical Genetics, Yorkhill Hospitals, Glasgow, United Kingdom

  ⨯
• Trevor Cole,

  Affiliation West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom

  ⨯
• Diana Eccles,

  Affiliation Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom

  ⨯
• Jackie Cook,

  Affiliation Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom

  ⨯
• Shirley Hodgson,

  Affiliation Clinical Genetics Department, St Georges Hospital, University of London, London, United Kingdom

  ⨯
• Carole Brewer,

  Affiliation Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom

  ⨯
• Marc Tischkowitz,

  Affiliation Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom

  ⨯
• Fiona Douglas,

  Affiliation Institute of Human Genetics, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom

  ⨯
• Mary Porteous,

  Affiliation South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom

  ⨯
• Lucy Side,

  Affiliation North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

  ⨯
• Lisa Walker,

  Affiliation Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom

  ⨯
• Patrick Morrison,

  Affiliation Northern Ireland Regional Genetics Centre, Belfast City Hospital, Belfast, United Kingdom

  ⨯
• Alan Donaldson,

  Affiliation South West Regional Genetics Service, Bristol, United Kingdom

  ⨯
• John Kennedy,

  Affiliation Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin and St James's Hospital, Dublin, Eire

  ⨯
• Claire Foo,

  Affiliation Cheshire & Merseyside Clinical Genetics Service, Liverpool Women's NHS Foundation Trust, Liverpool, United Kingdom

  ⨯
• Andrew K. Godwin,

  Affiliation Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America

  ⨯
• Rita Katharina Schmutzler,

  Affiliation Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany

  ⨯
• Barbara Wappenschmidt,

  Affiliation Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany

  ⨯
• Kerstin Rhiem,

  Affiliation Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany

  ⨯
• Christoph Engel,

  Affiliation Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany

  ⨯
• Alfons Meindl,

  Affiliation Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany

  ⨯
• Nina Ditsch,

  Affiliation Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany

  ⨯
• Norbert Arnold,

  Affiliation Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany

  ⨯
• Hans Jörg Plendl,

  Affiliation Institute of Human Genetics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany

  ⨯
• Dieter Niederacher,

  Affiliation Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany

  ⨯
• Christian Sutter,

  Affiliation Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany

  ⨯
• Shan Wang-Gohrke,

  Affiliation Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany

  ⨯
• Doris Steinemann,

  Affiliation Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany

  ⨯
• Sabine Preisler-Adams,

  Affiliation Institute of Human Genetics, University of Münster, Münster, Germany

  ⨯
• Karin Kast,

  Affiliation Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany

  ⨯
• Raymonda Varon-Mateeva,

  Affiliation Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany

  ⨯
• Andrea Gehrig,

  Affiliation Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany

  ⨯
• Dominique Stoppa-Lyonnet,

  Affiliations Institut Curie, Department of Tumour Biology, Paris, France, Institut Curie, INSERM U830, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, Paris, France

  ⨯
• Olga M. Sinilnikova,

  Affiliations Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon – Centre Léon Bérard, Lyon, France, INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France

  ⨯
• Sylvie Mazoyer,

  Affiliation INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France

  ⨯
• Francesca Damiola,

  Affiliation INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France

  ⨯
• Bruce Poppe,

  Affiliation Center for Medical Genetics, Ghent University, Ghent, Belgium

  ⨯
• Kathleen Claes,

  Affiliation Center for Medical Genetics, Ghent University, Ghent, Belgium

  ⨯
• Marion Piedmonte,

  Affiliation Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Kathy Tucker,

  Affiliation Prince of Wales Hospital. Sydney, Australia

  ⨯
• Floor Backes,

  Affiliation Ohio State University, Columbus Cancer Council, Columbus, Ohio, United States of America

  ⨯
• Gustavo Rodríguez,

  Affiliation Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, Illinois, United States of America

  ⨯
• Wendy Brewster,

  Affiliation Division of Gynecologic Oncology, NorthShore University HealthSystem, Chicago, Illinois, United States of America

  ⨯
• Katie Wakeley,

  Affiliation For Tufts Medical Center, Boston, Massachusetts, United States of America

  ⨯
• Thomas Rutherford,

  Affiliation Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Trinidad Caldés,

  Affiliation Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain

  ⨯
• Heli Nevanlinna,

  Affiliation Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Kristiina Aittomäki,

  Affiliation Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Matti A. Rookus,

  Affiliation Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands

  ⨯
• Theo A. M. van Os,

  Affiliation Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Lizet van der Kolk,

  Affiliation Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands

  ⨯
• J. L. de Lange,

  Affiliation Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands

  ⨯
• Hanne E. J. Meijers-Heijboer,

  Affiliation Department of Clinical Genetics, VU University Medical Centre, Amsterdam, The Netherlands

  ⨯
• A. H. van der Hout,

  Affiliation University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands

  ⨯
• Christi J. van Asperen,

  Affiliation Department of Clinical Genetics, Leiden University Medical Center Leiden, Leiden, The Netherlands

  ⨯
• Encarna B. Gómez Garcia,

  Affiliation Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, The Netherlands

  ⨯
• Nicoline Hoogerbrugge,

  Affiliation Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

  ⨯
• J. Margriet Collée,

  Affiliation Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• Carolien H. M. van Deurzen,

  Affiliation Department of Pathology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• Rob B. van der Luijt,

  Affiliation Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands

  ⨯
• Peter Devilee,

  Affiliation Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• HEBON ,

  ¶Full membership of SWE-BRCA, HEBON and kConFab Investigators is provided in the Acknowledgments.

  Affiliation The Hereditary Breast and Ovarian Cancer Research Group, Netherlands Cancer Institute, Amsterdam, The Netherlands

  ⨯
• Edith Olah,

  Affiliation Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary

  ⨯
• Conxi Lázaro,

  Affiliation Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain

  ⨯
• Alex Teulé,

  Affiliation Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain

  ⨯
• Mireia Menéndez,

  Affiliation Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain

  ⨯
• Anna Jakubowska,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Cezary Cybulski,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Jacek Gronwald,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Jan Lubinski,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Katarzyna Durda,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Katarzyna Jaworska-Bieniek,

  Affiliations Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland, Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland

  ⨯
• Oskar Th. Johannsson,

  Affiliation Department of Oncology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik Iceland

  ⨯
• Christine Maugard,

  Affiliation Laboratoire de Diagnostic Génétique et Service d'Onco-hématologie, Hopitaux Universitaire de Strasbourg, CHRU Nouvel Hôpital Civil, Strasbourg, France

  ⨯
• Marco Montagna,

  Affiliation Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy

  ⨯
• Silvia Tognazzo,

  Affiliation Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy

  ⨯
• Manuel R. Teixeira,

  Affiliation Department of Genetics, Portuguese Oncology Institute, Porto, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal

  ⨯
• Sue Healey,

  Affiliation Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• KConFab Investigators ,

  ¶Full membership of SWE-BRCA, HEBON and kConFab Investigators is provided in the Acknowledgments.

  Affiliation Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia

  ⨯
• Curtis Olswold,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Lucia Guidugli,

  Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Noralane Lindor,

  Affiliation Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America

  ⨯
• Susan Slager,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Csilla I. Szabo,

  Affiliation Center for Translational Cancer Research, Department of Biological Sciences, University of Delaware, Newark, Delaware, United States of America

  ⨯
• Joseph Vijai,

  Affiliations Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Mark Robson,

  Affiliation Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Noah Kauff,

  Affiliation Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Liying Zhang,

  Affiliation Diagnostic Molecular Genetics Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Rohini Rau-Murthy,

  Affiliation Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Anneliese Fink-Retter,

  Affiliation Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Christian F. Singer,

  Affiliation Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Christine Rappaport,

  Affiliation Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Daphne Geschwantler Kaulich,

  Affiliation Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Georg Pfeiler,

  Affiliation Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Muy-Kheng Tea,

  Affiliation Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Andreas Berger,

  Affiliation Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

  ⨯
• Catherine M. Phelan,

  Affiliation Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Mark H. Greene,

  Affiliation Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Phuong L. Mai,

  Affiliation Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Flavio Lejbkowicz,

  Affiliation Clalit National Israeli Cancer Control Center, Haifa, Israel

  ⨯
• Irene Andrulis,

  Affiliation Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, and Cancer Care Ontario, Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Anna Marie Mulligan,

  Affiliation Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada

  ⨯
• Gord Glendon,

  Affiliation Ontario Cancer Genetics Network: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯
• Amanda Ewart Toland,

  Affiliation Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Anders Bojesen,

  Affiliation Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark

  ⨯
• Inge Sokilde Pedersen,

  Affiliation Section of Molecular Diagnostics, Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark

  ⨯
• Lone Sunde,

  Affiliation Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Mads Thomassen,

  Affiliation Department of Clinical Genetics, Odense University Hospital, Odense, Denmark

  ⨯
• Torben A. Kruse,

  Affiliation Department of Clinical Genetics, Odense University Hospital, Odense, Denmark

  ⨯
• Uffe Birk Jensen,

  Affiliation Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Eitan Friedman,

  Affiliation Sheba Medical Center, Tel Aviv, Israel

  ⨯
• Yael Laitman,

  Affiliation Sheba Medical Center, Tel Aviv, Israel

  ⨯
• Shani Paluch Shimon,

  Affiliation Sheba Medical Center, Tel Aviv, Israel

  ⨯
• Jacques Simard,

  Affiliation Canada Research Chair in Oncogenetics, Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada

  ⨯
• Douglas F. Easton,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Kenneth Offit,

  Affiliations Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Fergus J. Couch,

  Affiliations Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Georgia Chenevix-Trench,

  Affiliation Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia

  ⨯
• Antonis C. Antoniou,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
•  [ ... ],
• Javier Benitez

  Affiliations Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain, Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain, Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain

  ⨯
• [ view all ]
• [ view less ]